Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding CollPlant Biotechnologies Ltd changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CLGN: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders16213−1
Shares1.49M316.2K1.24M+62.7K (+5.3%)
Value$7.39M$1.57M$6.79M+$966.1K (+16.6%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CLGN in Q3 2024
InstitutionSharesValue% of portfolio
Benjamin Edwards Inc23,810$111.9K0.00%
Pathstone Holdings, LLC17,000$84.4K0.00%
Wells Fargo & Company4,000$19.9K0.00%

Sold out (4)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CLGN in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
The PNC Financial Services Group, Inc.3,600$17.9K
Redwood Wealth Management Group, LLC1,310$6.51K
Qube Research & Technologies Ltd6$30
Tower Research Capital LLC (TRC)1$5

Not filed for Q3 2024 yet (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLGN in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Roumell Asset Management, LLC276,430$1.37M
Benjamin F. Edwards & Company, Inc.39,760$197.0K